ArticleiLIVER2025

Corrigendum to "Effects of Raf kinase inhibitor protein on biological characteristics of hepatocellular carcinoma cells and its potential therapeutic effects" [iLIVER 1 (2022) 275-282].

Zhang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.